Point72 Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-320,665
| Closed | -$29.5M | – | 2538 |
|
|
2025
Q2 | $28M | Buy |
320,665
+301,917
| +1,610% | +$25.6M | 0.05% | 389 |
|
|
2025
Q1 | $1.68M | Sell |
18,748
-1,005,161
| -98% | -$89.9M | ﹤0.01% | 1293 |
|
|
2024
Q4 | $81.8M | Buy |
1,023,909
+102,209
| +11% | +$8.85M | 0.18% | 126 |
|
|
2024
Q3 | $83M | Buy |
+921,700
| New | +$77.5M | 0.21% | 111 |
|
|
2024
Q1 | – | Sell |
-440,881
| Closed | -$37.6M | – | 2448 |
|
|
2023
Q4 | $36.3M | Sell |
440,881
-148,181
| -25% | -$11.3M | 0.09% | 281 |
|
|
2023
Q3 | $46.2M | Sell |
589,062
-460,200
| -44% | -$38.5M | 0.13% | 186 |
|
|
2023
Q2 | $92.4M | Buy |
1,049,262
+395,081
| +60% | +$34M | 0.27% | 82 |
|
|
2023
Q1 | $52.7M | Buy |
654,181
+647,619
| +9,869% | +$52.8M | 0.16% | 158 |
|
|
2022
Q4 | $510K | Buy |
+6,562
| New | +$532K | ﹤0.01% | 1147 |
|
|
2022
Q2 | – | Sell |
-284,787
| Closed | -$28.9M | – | 1536 |
|
|
2022
Q1 | $31.6M | Buy |
+284,787
| New | +$30.1M | 0.13% | 219 |
|
|
2021
Q2 | – | Sell |
-437,100
| Closed | -$51.6M | – | 1089 |
|
|
2021
Q1 | $51.6M | Buy |
437,100
+426,626
| +4,073% | +$50M | 0.24% | 101 |
|
|
2020
Q4 | $1.23M | Sell |
10,474
-512,561
| -98% | -$56.4M | 0.01% | 787 |
|
|
2020
Q3 | $54.4M | Sell |
523,035
-22,682
| -4% | -$2.28M | 0.28% | 85 |
|
|
2020
Q2 | $50M | Buy |
545,717
+487,925
| +844% | +$46.8M | 0.33% | 77 |
|
|
2020
Q1 | $5.21M | Sell |
57,792
-1,048,407
| -95% | -$112M | 0.04% | 377 |
|
|
2019
Q4 | $125M | Buy |
1,106,199
+1,097,799
| +13,069% | +$120M | 0.66% | 22 |
|
|
2019
Q3 | $912K | Sell |
8,400
-189,169
| -96% | -$19.7M | 0.01% | 709 |
|
|
2019
Q2 | $19.2M | Sell |
197,569
-316,169
| -62% | -$28.9M | 0.1% | 256 |
|
|
2019
Q1 | $46.8M | Sell |
513,738
-866,446
| -63% | -$77.5M | 0.21% | 120 |
|
|
2018
Q4 | $126M | Buy |
1,380,184
+1,333,784
| +2,875% | +$125M | 0.61% | 32 |
|
|
2018
Q3 | $4.56M | Sell |
46,400
-777,222
| -94% | -$71.9M | 0.02% | 618 |
|
|
2018
Q2 | $70.5M | Buy |
823,622
+82,423
| +11% | +$6.88M | 0.28% | 95 |
|
|
2018
Q1 | $59.5M | Sell |
741,199
-847,826
| -53% | -$69.9M | 0.25% | 110 |
|
|
2017
Q4 | $128M | Buy |
+1,589,025
| New | +$127M | 0.55% | 32 |
|
|
2017
Q2 | – | Sell |
-186,100
| Closed | -$15M | – | 939 |
|
|
2017
Q1 | $15M | Buy |
+186,100
| New | +$14.5M | 0.08% | 306 |
|
|
2016
Q3 | – | Sell |
-125,000
| Closed | -$10.8M | – | 801 |
|
|
2016
Q2 | $10.8M | Buy |
+125,000
| New | +$10.1M | 0.07% | 284 |
|
|
2016
Q1 | – | Sell |
-461,800
| Closed | -$35.5M | – | 797 |
|
|
2015
Q4 | $35.5M | Sell |
461,800
-39,100
| -8% | -$2.94M | 0.29% | 103 |
|
|
2015
Q3 | $33.5M | Sell |
500,900
-95,500
| -16% | -$7.03M | 0.26% | 113 |
|
|
2015
Q2 | $44.2M | Buy |
596,400
+460,200
| +338% | +$35.2M | 0.31% | 88 |
|
|
2015
Q1 | $10.6M | Sell |
136,200
-522,700
| -79% | -$39.6M | 0.07% | 318 |
|
|
2014
Q4 | $47.6M | Buy |
658,900
+393,600
| +148% | +$27.3M | 0.33% | 91 |
|
|
2014
Q3 | $16.4M | Sell |
265,300
-667,700
| -72% | -$42.5M | 0.12% | 212 |
|
|
2014
Q2 | $59.5M | Buy |
+933,000
| New | +$56.7M | 0.38% | 69 |
|
Other funds holding MDT
VCM
VPM
Point72 Asset Management's MDT Position: Q3 2025 in Review
Point72 Asset Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 320,665 shares — an estimated $29.5M sold.
Point72 Asset Management first reported a position in MDT in Q2 2014 and held it in 33 quarters. The position peaked at $128M in Q4 2017. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.
- Point72 Asset Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
- Point72 Asset Management sold 320,665 Medtronic shares in Q3 2025, an estimated $29.5M.
- Point72 Asset Management first reported a position in Medtronic in Q2 2014 and held it in 33 quarters.
- Point72 Asset Management's Medtronic position peaked at $128M in Q4 2017.
- 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.
Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.